United States
Germany
Japan
United Kingdom
China
KIR2DS4 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
Products
KIR2DS4 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
KIR2DS4 CRISPRa kit - CRISPR gene activation of human killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
CD158i / KIR2DS4 human recombinant protein, 0.1 mg
| Expression Host | E. coli |
CD158i / KIR2DS4 human protein, 0.5 mg
| Expression Host | E. coli |
KIR2DS4 (untagged)-Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 (KIR2DS4)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
KIR2DS4 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
KIR2DS4 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
KIR2DS4 (untagged) - Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 (KIR2DS4), transcript variant 2 (KIR2DS4*003 allele)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
KIR2DS4 (untagged) - Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 (KIR2DS4), transcript variant 3
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
qSTAR qPCR primer pairs against Homo sapiens gene KIR2DS4
KIR2DS4 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
